3 results match your criteria: "USA Masonic Cancer Center[Affiliation]"
Haematologica
October 2016
Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA Center for Allied Health Programs, University of Minnesota, Minneapolis, MN, USA.
Juvenile myelomonocytic leukemia is a rare myeloproliferative neoplasm characterized by hyperactive RAS signaling. Neurofibromin1 (encoded by the NF1 gene) is a negative regulator of RAS activation. Patients with neurofibromatosis type 1 harbor loss-of-function mutations in NF1 and have a 200- to 500-fold increased risk of juvenile myelomonocytic leukemia.
View Article and Find Full Text PDFNucleic Acids Res
January 2015
Department of Obstetrics, Gynecology & Women's Health, University of Minnesota, Minneapolis, MN 55455, USA Department of Genetics, Cell Biology & Development, University of Minnesota, Minneapolis, MN 55455, USA Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA
Identification of cancer driver gene mutations is crucial for advancing cancer therapeutics. Due to the overwhelming number of passenger mutations in the human tumor genome, it is difficult to pinpoint causative driver genes. Using transposon mutagenesis in mice many laboratories have conducted forward genetic screens and identified thousands of candidate driver genes that are highly relevant to human cancer.
View Article and Find Full Text PDFNucleic Acids Res
May 2014
Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN 55455, USA Masonic Cancer Center, Minneapolis, MN 55455, USA
Accumulating evidence suggests that dormant DNA replication origins play an important role in the recovery of stalled forks. However, their functional interactions with other fork recovery mechanisms have not been tested. We previously reported intrinsic activation of the Fanconi anemia (FA) pathway in a tumor-prone mouse model (Mcm4chaos3) with a 60% loss of dormant origins.
View Article and Find Full Text PDF